Cargando…
Metformin and berberine, two versatile drugs in treatment of common metabolic diseases
Metformin has been used as a glucose lowering drug for several centuries and is now a first-line drug for type 2 diabetes mellitus (T2DM). Since the discovery that it activates AMP-activated protein kinase (AMPK) and reduces risk of cancer, metformin has drawn great attentions. Another drug, berberi...
Autores principales: | Wang, Haoran, Zhu, Chen, Ying, Ying, Luo, Lingyu, Huang, Deqiang, Luo, Zhijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839379/ https://www.ncbi.nlm.nih.gov/pubmed/29515798 http://dx.doi.org/10.18632/oncotarget.20807 |
Ejemplares similares
-
Metformin attenuates trauma‐induced heterotopic ossification via inhibition of Bone Morphogenetic Protein signalling
por: Lin, Hui, et al.
Publicado: (2020) -
AMP‐activated protein kinase regulates cancer cell growth and metabolism via nuclear and mitochondria events
por: Jiang, Shanshan, et al.
Publicado: (2019) -
MLK3 Phophorylates AMPK Independently of LKB1
por: Luo, Lingyu, et al.
Publicado: (2015) -
Application of electrogastrogram in assessment of gastric motility in acute pancreatitis
por: Cai, Ying, et al.
Publicado: (2023) -
Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats
por: Hu, Yueshan, et al.
Publicado: (2014)